# EDGAR Filing Document

**Accession Number:** 0001958125
**File Stem:** 0001958125-25-000006
**Filing Date:** 2025-8
**Character Count:** 15553
**Document Hash:** f2790ec83025c993ed20c3b6aa285d18
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001958125-25-000006.hdr.sgml**: 20250811

**ACCESSION NUMBER**: 0001958125-25-000006

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250811

**EFFECTIVENESS DATE**: 20250811

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Catalio Capital Management, LP
- **CENTRAL INDEX KEY:** 0001958125

**ORGANIZATION NAME:**
- **EIN:** 851427184
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-25237
- **FILM NUMBER:** 251201022

**BUSINESS ADDRESS:**
- **STREET 1:** 512 W. 22ND STREET
- **STREET 2:** 5TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011
- **BUSINESS PHONE:** 410-989-6168

**MAIL ADDRESS:**
- **STREET 1:** 512 W. 22ND STREET
- **STREET 2:** 5TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001958125

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Catalio Capital Management, LP

**Address:** 512 W. 22ND STREET, NEW YORK, NY 10011

**Telephone number:** 410-989-6168

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-25237

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                         | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Masimo Corp                   | 574795100 | 07/25/2024     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          24676 |                0 | ABSTAIN     |                                    24676 | NONE                        |  |
| Becton Dickinson  Co          | 075887109 | 01/28/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         106096 |                0 | FOR         |                                   106096 | FOR                         |  |
| Karyopharm Therapeutics Inc   | 48576U205 | 01/30/2025     | Non-binding, Advisory Vote to approve executive compensation                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1756340 |                0 | FOR         |                                  1756340 | FOR                         |  |
| Masimo Corp                   | 574795100 | 04/29/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          92411 |                0 | FOR         |                                    92411 | FOR                         |  |
| Inspire Medical Systems Inc   | 457730109 | 05/01/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          82214 |                0 | FOR         |                                    82214 | FOR                         |  |
| Intuitive Surgical Inc        | 46120E602 | 05/01/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          62857 |                0 | FOR         |                                    62857 | FOR                         |  |
| Eli Lilly  Co                 | 532457108 | 05/05/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          24791 |                0 | FOR         |                                    24791 | FOR                         |  |
| Edwards Lifesciences Corp     | 28176E108 | 05/08/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         311563 |                0 | FOR         |                                   311563 | FOR                         |  |
| Lonza Group AG                | H50524133 | 05/09/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          46529 |                0 | ABSTAIN     |                                    46529 | NONE                        |  |
| Cytokinetics Inc              | 23282W605 | 05/14/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         585812 |                0 | FOR         |                                   585812 | FOR                         |  |
| SpringWorks Therapeutics Inc  | 85205L107 | 05/14/2025     | Non-binding, Advisory Vote to approve executive compensation                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         678677 |                0 | FOR         |                                   678677 | FOR                         |  |
| Syndax Pharmaceuticals Inc    | 87164F105 | 05/14/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        1537587 |                0 | FOR         |                                  1537587 | FOR                         |  |
| Hyperfine Inc                 | 44916K106 | 05/19/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         260035 |                0 | FOR         |                                   260035 | FOR                         |  |
| Ascendis Pharma A/S           | 04351P101 | 05/27/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         185600 |                0 | FOR         |                                   185600 | FOR                         |  |
| Argenx SE                     | N0610Q109 | 05/27/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          35898 |                0 | FOR         |                                    35898 | FOR                         |  |
| Karyopharm Therapeutics Inc   | 48576U205 | 05/28/2025     | Advisory vote to approve the executive compensation.  Advisory vote to approve the frequency of an advisory vote on executive compensation.              | SECTION 14A SAY-ON-PAY VOTES |         117086 |                0 | FOR         |                                   117086 | FOR                         |  |
| Kyverna Therapeutics Inc      | 501976104 | 05/29/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         586909 |                0 | FOR         |                                   586909 | FOR                         |  |
| Vir Biotechnology Inc         | 92764N102 | 05/29/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         611608 |                0 | FOR         |                                   611608 | FOR                         |  |
| Outset Medical Inc            | 690145206 | 06/02/2025     | Non-binding, Advisory Vote to approve executive compensation                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         166666 |                0 | FOR         |                                   166666 | FOR                         |  |
| MoonLake Immunotherapeutics   | 61559X104 | 06/05/2025     | Non-binding, Advisory Vote to approve executive compensation                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         152028 |                0 | FOR         |                                   152028 | FOR                         |  |
| Soleno Therapeutics Inc       | 834203309 | 06/05/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         344854 |                0 | FOR         |                                   344854 | FOR                         |  |
| Adaptive Biotechnologies Corp | 00650F109 | 06/10/2025     | Non-binding, Advisory Vote to approve executive compensation                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1244118 |                0 | FOR         |                                  1244118 | FOR                         |  |
| Zenas Biopharma Inc           | 98937L105 | 06/10/2025     | Non-binding, Advisory Vote to approve executive compensation                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         275241 |                0 | FOR         |                                   275241 | FOR                         |  |
| uniQure NV                    | N90064101 | 06/11/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         513240 |                0 | FOR         |                                   513240 | FOR                         |  |
| Protara Therapeutics Inc      | 74365U107 | 06/11/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         706370 |                0 | FOR         |                                   706370 | FOR                         |  |
| Mersana Therapeutics Inc      | 59045L205 | 06/12/2025     | Non-binding, Advisory Vote to approve executive compensation                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1567413 |                0 | FOR         |                                  1567413 | FOR                         |  |
| Natera Inc                    | 632307104 | 06/12/2025     | Non-binding, Advisory Vote to approve executive compensation                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          27350 |                0 | FOR         |                                    27350 | FOR                         |  |
| Structure Therapeutics Inc    | 86366E106 | 06/23/2025     | Advisory vote to approve the executive compensation.  Advisory vote to approve the frequency of an advisory vote on executive compensation.              | SECTION 14A SAY-ON-PAY VOTES |         670575 |                0 | FOR         |                                   670575 | FOR                         |  |
| Veracyte Inc                  | 92337F107 | 06/17/2025     | Non-binding, Advisory vote to approve the executive compensation.  Advisory vote to approve the frequency of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |         719421 |                0 | FOR         |                                   719421 | FOR                         |  |
| Bridgebio Pharma Inc          | 10806X102 | 06/20/2025     | Advisory vote to approve the executive compensation.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        1066534 |                0 | FOR         |                                  1066534 | FOR                         |  |
| Fulcrum Therapeutics Inc      | 359616109 | 06/26/2025     | Non-binding, Advisory Vote to approve executive compensation                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         188304 |                0 | FOR         |                                   188304 | FOR                         |  |
| Dianthus Therapeutics, Inc.   | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our namedexecutive officers.                                                                  | SECTION 14A SAY-ON-PAY VOTES |         535539 |                0 | FOR         |                                   535539 | FOR                         |  |
| PROTARA THERAPEUTICS, INC.    | 74365U107 | 06/10/2025     | Approval, on an advisory basis, of the compensation of Protara Therapeutics, Inc.'s named executive officers.                                            | SECTION 14A SAY-ON-PAY VOTES |         320000 |                0 | ABSTAIN     |                                   320000 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Catalio Capital Management, LP

**By (Signature):** Olga Maltseva

**By (Printed Signature):** Olga Maltseva

**By (Title):** Chief Compliance Officer and Head of Operations

**Date:** 08/11/2025